SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-582026
Filing Date
2016-05-06
Accepted
2016-05-06 16:18:55
Documents
49
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d138364d10q.htm 10-Q 541358
2 EX-31.1 d138364dex311.htm EX-31.1 6019
3 EX-31.2 d138364dex312.htm EX-31.2 6078
4 EX-32.1 d138364dex321.htm EX-32.1 4593
11 GRAPHIC g138364g27p69.jpg GRAPHIC 39576
  Complete submission text file 0001193125-16-582026.txt   2508534

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sage-20160331.xml EX-101.INS 301663
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20160331.xsd EX-101.SCH 35003
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20160331_cal.xml EX-101.CAL 35607
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20160331_def.xml EX-101.DEF 115795
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20160331_lab.xml EX-101.LAB 269147
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20160331_pre.xml EX-101.PRE 196869
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 161628312
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences